Related content

Type 2 diabetes: Does pancreatic fat really matter?

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 34, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are Elements of the Chronic Care Model Associated with Cardiovascular Risk Factor Control in Type 2 Diabetes?

By Parchman Michael   Kaissi Amer A.  

Joint Commission Journal on Quality and Patient Safety, Vol. 35, Iss. 3, 2009-03 ,pp. : 133-138

Joint Commission Resources

Access to resources Recommend Favorite

Impact of an integrated model of care on potentially preventable hospitalizations for people with Type 2 diabetes mellitus

By  

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 872-880

John Wiley & Sons Inc

Access to resources Recommend Favorite

What Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model

By Palmer Andrew J.   Roze Stéphane   Valentine William J.   Minshall Michael E.   Lammert Morten   Oglesby Alan   Hayes Clarice   Spinas Giatgen A.  

Current Medical Research and Opinion, Vol. 20, Iss. 1, 2004-08 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Patient preferences for diabetes management among people with type 2 diabetes in Denmark – a discrete choice experiment

By Bøgelund Mette   Vilsbøll Tina   Faber Jens   Henriksen Jan Erik   Gjesing Rasmus Prior   Lammert Morten  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2175-2183

Informa Healthcare

Access to resources Recommend Favorite